| Bioactivity | GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity. |
| Target | Target: Cholecystokinin 1 receptor |
| Name | GI 181771 |
| CAS | 305366-98-7 |
| Formula | C34H31N5O6 |
| Molar Mass | 605.64 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Myer JR, et al. Species- and dose-specific pancreatic responses and progression in single- and repeat-dose studies with GI181771X: a novel cholecystokinin 1 receptor agonist in mice, rats, and monkeys. Toxicol Pathol. 2014 Jan;42(1):260-74. [2]. Roses AD, et al. Stimulation of cholecystokinin-A receptors with Gl181771X: a failed clinical trial that did not test the pharmacogenetic hypothesis for reduction of food intake. Clin Pharmacol Ther. 2009 Apr;85(4):362-5. |